A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Deoxy Bosentan | CAS 157415-45-7 - Request Quote

Picture of Deoxy Bosentan

Deoxy Bosentan

SZ CAT No:SZ-B017025
CAS No
157415-45-7
Mol.F.
C27H29N5O5S
Mol.Wt.
535.6
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Deoxy Bosentan is chemically 4-(Tert-butyl)-N-(6-ethoxy-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)benzenesulfonamide. Deoxy Bosentan is supplied with detailed characterization data compliant with regulatory guideline. Deoxy Bosentan can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Bosentan.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 157415-45-7

Purchase 157415-45-7

Order 157415-45-7

Enquire 157415-45-7

price of 157415-45-7

157415-45-7 Supplier

157415-45-7 Manufacturer

157415-45-7 Exporter

buy high quality Deoxy Bosentan

Purchase Deoxy Bosentan

Deoxy Bosentan suppliers

Deoxy Bosentan manufacturers

Deoxy Bosentan price

Order Deoxy Bosentan

Enquire Deoxy Bosentan

Deoxy Bosentan cost

Deoxy Bosentan Supplier

Deoxy Bosentan Distributor

Deoxy Bosentan for Method Validation

Bosentan Reference Standard

Deoxy Bosentan for ANDA Filing

Deoxy Bosentan for Forced Degradation Studies

Deoxy Bosentan Identification Standards

Deoxy Bosentan for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,